Vanguard Group »

Monte Rosa Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.0M 1.6M 5.65
2023-09-30 $7.8M 1.6M 4.79
2023-06-30 $11M 1.6M 6.85
2023-03-31 $11M 1.4M 7.79
2022-12-31 $11M 1.4M 7.61
2022-06-30 $22M 2.3M 9.67
2022-03-31 $42M 3.0M 14.02
2021-09-30 $23M 1.0M 22.28
2021-06-30 $2.3M 100k 22.54